Schilsky, MD, FACP, chief medical officer at the American Society of Clinical Oncology, which issued a critical position statement on access to experimental drugs in spring 2017.
To develop an evidence-based guideline on prostate cancer chemoprevention, the American Society of Clinical Oncology and the American Urological Association did a systematic literature review of 15 randomized clinical trials
Residency: University of Arizona, 1991 (chief resident, 1992). Fellowship: University of Arizona (general medicine, medical oncology, NIH cancer prevention and etiology). ... Current patient care activities: Medical oncology/women's cancer, 25%. Current
Twitter. Dr. Just has 36 years in clinical practice of hematology and medical oncology.
Rituximab. The correct answer is C: Topical glucocorticoids. This question can be found in MKSAP 17 in the Hematology and Oncology section, item 118.
Oncology is advancing rapidly these days with new and powerful insights about immunology, but progress has lagged behind cardiology and endocrinology in part for want of markers that show in the
Regional variations in the cost of care are “rampant,” according to an opinion piece in the June 10 Annals by Eric Horwitz, MD, chair of the department of radiation oncology and
This question can be found in MKSAP 16 in the Hematology and Oncology section, item 51.
Our Conference Coverage section is from the American Society of Clinical Oncology's annual meeting in June. ... In oncology, pain, fatigue, nausea, and depression are the variables most commonly measured, but this approach can be helpful in other fields,
Results appeared in the Journal of Clinical Oncology. Among girls ages 15 to 17, adjusted efficacy estimates were 35% (95% CI, 19% to 65%) for high-grade squamous intraepithelial lesions, 21%